DD143768A5 - Verfahren zur herstellung von pyrrolidon-verbindungen - Google Patents

Verfahren zur herstellung von pyrrolidon-verbindungen Download PDF

Info

Publication number
DD143768A5
DD143768A5 DD77213369A DD21336977A DD143768A5 DD 143768 A5 DD143768 A5 DD 143768A5 DD 77213369 A DD77213369 A DD 77213369A DD 21336977 A DD21336977 A DD 21336977A DD 143768 A5 DD143768 A5 DD 143768A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
pyrrolidone
compound
group
preparation
Prior art date
Application number
DD77213369A
Other languages
German (de)
English (en)
Inventor
Albin J Nelson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD143768A5 publication Critical patent/DD143768A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD77213369A 1976-08-06 1977-08-05 Verfahren zur herstellung von pyrrolidon-verbindungen DD143768A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (1)

Publication Number Publication Date
DD143768A5 true DD143768A5 (de) 1980-09-10

Family

ID=24861795

Family Applications (2)

Application Number Title Priority Date Filing Date
DD77213369A DD143768A5 (de) 1976-08-06 1977-08-05 Verfahren zur herstellung von pyrrolidon-verbindungen
DD77200468A DD136135A5 (de) 1976-08-06 1977-08-05 Verfahren zur herstellung neuer pyrrolidinverbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD77200468A DD136135A5 (de) 1976-08-06 1977-08-05 Verfahren zur herstellung neuer pyrrolidinverbindungen

Country Status (31)

Country Link
JP (2) JPS5321159A (fi)
AR (1) AR217080A1 (fi)
AT (1) AT362887B (fi)
AU (1) AU508007B2 (fi)
BE (1) BE857506A (fi)
BG (1) BG31073A3 (fi)
CA (1) CA1077948A (fi)
CH (1) CH624934A5 (fi)
CS (1) CS221269B2 (fi)
DD (2) DD143768A5 (fi)
DE (1) DE2735904A1 (fi)
DK (1) DK352077A (fi)
ES (2) ES461388A1 (fi)
FI (1) FI70009C (fi)
FR (1) FR2369260A1 (fi)
GB (2) GB1556569A (fi)
GR (1) GR68688B (fi)
HU (1) HU180273B (fi)
IE (1) IE45505B1 (fi)
IL (1) IL52615A (fi)
LU (1) LU77936A1 (fi)
NL (1) NL7708637A (fi)
NO (1) NO772752L (fi)
NZ (1) NZ184806A (fi)
PH (1) PH17398A (fi)
PL (2) PL112931B1 (fi)
PT (1) PT66891B (fi)
SE (1) SE423813B (fi)
SU (3) SU703016A3 (fi)
YU (1) YU192577A (fi)
ZA (1) ZA774704B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
JPS59137224A (ja) * 1983-01-25 1984-08-07 Mitsubishi Electric Corp 電気鉄道用き電電圧補償装置
ATE327751T1 (de) 2000-01-31 2006-06-15 Pfizer Prod Inc Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz
WO2002024647A1 (fr) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine
PT1339678E (pt) * 2000-11-27 2007-11-30 Pfizer Prod Inc Agonistas selectivos do receptor ep4 no tratamento de osteoporose
TWI313608B (en) * 2001-07-23 2009-08-21 Ono Pharmaceutical Co Lower bone mass treating agent containing er4 agonist as active ingredient
MXPA04005555A (es) * 2002-03-18 2005-05-16 Pfizer Prod Inc Procedimientos de tratamiento con agonistas selectivos del receptor ep4.
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
US7256211B1 (en) * 2003-01-21 2007-08-14 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medical use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA1077948A (en) 1980-05-20
SE7708642L (sv) 1978-02-07
GB1556570A (en) 1979-11-28
PL200124A1 (pl) 1978-05-22
AR217080A1 (es) 1980-02-29
JPS5555161A (en) 1980-04-22
GR68688B (fi) 1982-02-01
IL52615A0 (en) 1977-10-31
ZA774704B (en) 1978-06-28
JPS5531147B2 (fi) 1980-08-15
SE423813B (sv) 1982-06-07
YU192577A (en) 1983-04-30
IL52615A (en) 1981-09-13
IE45505L (en) 1978-02-06
CS221269B2 (en) 1983-04-29
BE857506A (fr) 1978-02-06
NL7708637A (nl) 1978-02-08
FR2369260B1 (fi) 1982-02-12
AU2751577A (en) 1979-02-08
NZ184806A (en) 1980-04-28
AT362887B (de) 1981-06-25
PH17398A (en) 1984-08-08
NO772752L (no) 1978-02-07
JPS585196B2 (ja) 1983-01-29
ATA579477A (de) 1980-11-15
FI70009B (fi) 1986-01-31
FI70009C (fi) 1986-09-12
PT66891B (en) 1979-01-26
SU850000A3 (ru) 1981-07-23
FI772376A (fi) 1978-02-07
DE2735904A1 (de) 1978-02-09
LU77936A1 (fi) 1978-04-27
ES461388A1 (es) 1978-12-01
BG31073A3 (en) 1981-10-15
DD136135A5 (de) 1979-06-20
IE45505B1 (en) 1982-09-08
JPS5321159A (en) 1978-02-27
DK352077A (da) 1978-02-07
AU508007B2 (en) 1980-03-06
HU180273B (en) 1983-02-28
PL112931B1 (en) 1980-11-29
GB1556569A (en) 1979-11-28
ES471349A1 (es) 1979-09-16
CH624934A5 (fi) 1981-08-31
FR2369260A1 (fr) 1978-05-26
SU703016A3 (ru) 1979-12-05
SU818480A3 (ru) 1981-03-30
PT66891A (en) 1977-09-01

Similar Documents

Publication Publication Date Title
US4177346A (en) 1,5-Disubstituted-2-pyrrolidones
DD143768A5 (de) Verfahren zur herstellung von pyrrolidon-verbindungen
DE2902438A1 (de) 2-pyrrolidonderivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung pharmakologisch brauchbarer verbindungen
EP0273270B1 (de) Verfahren zur Herstellung von (+)-Biotin
CH412889A (de) Verfahren zur Herstellung von 2-Methyl-3-oxypyridinen
CH653028A5 (de) Benzthiophenallylamin-verbindungen und verfahren zu ihrer herstellung.
DE3927370A1 (de) Verfahren zur herstellung von clausenamid und neoclausenamid und deren derivate
EP0542671B1 (de) Substituierte Hydrochinonderivate als Zwischenprodukte von Benzofuranderivaten
DE2452536A1 (de) Pyrrolidone und verfahren zu ihrer herstellung
DE2825855C3 (de) 15-substituierte-ι-Pentanorprostaglandin-derivate
DE2618861A1 (de) 11-oxa-prostaglandinanaloga, ihre derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0065200B1 (de) Delta-1-Pyrrolin-thiolactimäther und Verfahren zu ihrer Herstellung
DE2707404C3 (de) Verfahren zur Herstellung von 5,6-Dehydropenicillinen
DE2618721C2 (de) Benzo(b)-bicyclo[3,3,1]nonene, Verfahren zu deren Herstellung und pharmazeutische Mittel, die diese Verbindungen enthalten
DE69219804T2 (de) Phosphor enthaltende Azetidin-2-on-Derivate
DE2559093C3 (de) 2-Desarboxy-2-[tetrazol-5-yl]-11-desoxy-ω-pentanorprostaglandine der E- oder F-Reihe und deren C↓15↓-Epimere
DE2604248A1 (de) Verfahren zur herstellung von thienopyridinderivaten
KR810000657B1 (ko) 피롤리돈 화합물의 제조방법
DE2613701C2 (fi)
AT343648B (de) Verfahren zur herstellung neuer substituierter, gegebenenfalls veresterter oder amidierter benzocycloalkenylcarbonsauren
DE2613306C2 (fi)
DE2829823A1 (de) Verfahren zur herstellung von r,s- 2,3,5,6-tetrahydro-6-phenyl-imidazo (2,1-b)-thiazol (tetramisol)
EP0101602A1 (de) In 6-Stellung unsubstituierte 7-Oxo-4-oxa-diazabicyclo-(3.2.0)-hept-2-en Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Zwischenprodukte zur Synthese von beta-Lactamantibiotika
DE2417973A1 (de) 2- eckige klammer auf 1-(3,5-dimethoxyphenyl)-aethyl eckige klammer zu -heptylniedrigalkan-sulfonate und verfahren zu ihrer herstellung
CH631441A5 (de) Verfahren zur herstellung neuer cyclopentanderivate.